3 3 3 neurochem method one major difficulti risk assess estim exposur paramet dose bodi burden actual absorb individu epidemiolog studi actual absorpt bioavail chemic exposur frequent unknown measur chemic concentr biolog fluid tissu one way measur precis concentr site toxic effect epidemiolog studi possibl chronic exposur acut exposur chemic long biolog half live bodi lead metal bromid blood lead level show correl neurobehavior impair blood lead level repres correl toxic rel acut dose children exampl major lead relat impair result chronic rather acut absorpt cumul amount lead sequest tissu decidu teeth may repres indic area time concentr curv chemic half live bodi short estim absorb dose biochem product chemic physiolog effect chemic may serv index exposur serum enzym concentr cholinesteras esteras tissu lymphocyt target esteras employ field studi detect pesticid exposur vanillylmandel acid product catecholamin neurotransmitt biotransform erythrocyt protoporphyrin concentr use vari success differenti lead expos control worker addit similar exposur biomark measur laboratori studi may allow develop quantit estim absorb dose variou exposur condit measur metabol product neurotox agent may extrem use risk assess exampl come cancer risk assess human data earli 1970 satur microsom methylen chlorid biotransform carbon monoxid stewart et al 1972 along subsequ anim carcinogenesi data garner 1980 provid quantit basi physiolog base pharmacokinet model methylen chlorid cancer risk assess andersen et al 1991 inform human co pathway kinet provid homolog key allow extrapol risk anim human compar physiolog basi rather use default assumpt 3 3 4 imag techniqu number recent develop computer imag techniqu evalu brain activ cerebr peripher blood flow ad valuabl inform neurolog diagnost process imag method includ thermographi positron emiss tomographi passiv neuromagnet imag magnetoencephalographi magnet reson imag magnet reson spectroscopi computer tomographi doppler ultrasonographi computer eeg record analysi brain electr activ map research applic invas noninvas quantit method primarili neurolog schizophrenia research drug abus aid research toxic encephalopathi hagstadiu et al 1989 although equip brain imag expens portabl neuroimag techniqu promis valuabl clinic laboratori research tool human neurotoxicolog 3 3 5 neuropatholog method neuropatholog examin nervou system tissu use confirm data clinic test contribut understand mechan action neurotox peripher nerv biopsi confirm chemic induc peripher neuropathi evalu rate recoveri fullerton 1969 postmortem examin nervou tissu also elucid neuropatholog effect carbon disulfid clioquinol doxorubicin spencer schaumburg 1980 3 3 6 self report assess method self report measur relev neurotox risk assess consist histori symptom event behavior environment condit inform obtain face face interview structur interview often conduct diagnost purpos medic histori questionnair survey instrument self report instrument mean measur symptom interocept state pain nausea self report also use obtain inform behavior event e g exposur condit especi practic legal ethic limit prevent direct observ subject symptom elucid self report instrument respons dose hanninen et al 1979 found subject symptom posit correl blood lead level expos worker subject pain estim correl dose type central peripher act analges anxieti score varieti scale respons size anxiolyt dose